STEVENSVILLE, Md., Nov. 7 /PRNewswire-USNewswire/ -� Vapotherm, the leading developer and manufacturer of High Flow Oxygen Therapy products, has earned an Export Achievement Certificate from the U.S. Department of Commerce. Vapotherm was one of three Maryland companies to receive this designation at a recent ceremony in Wye Mills, Maryland. The Export Achievement Certificate was created by the U.S. Department of Commerce to recognize small and medium-sized enterprises that have successfully entered the international marketplace for the first time or that have successfully entered a new market. "Vapotherm has been on a progressive international expansion course and we are now distributed in over 20 countries outside the U.S. and our success abroad has not only provided an important new technology for the global respiratory community, but it has also helped to strengthen our domestic base," said Kevin Thibodeau, Vice President of Sales and Marketing for Vapotherm. The US Department of Commerce Export Assistance and the State of Maryland Export Assistance has been a valuable resource for use as we expand globally. "We are excited about Vapotherm's rapid growth in international markets. Vapotherm is a great example of a small company that is able to succeed internationally due to its advanced technology, corporate leadership and commitment to developing markets overseas. With ninety five percent of the world's market outside of the United States, Vapotherm is well positioned in these markets for future growth," said Bill Burwell, Director of the U.S. Commercial Service in Baltimore. Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit http://www.vtherm.com.
SOURCE Vapotherm, Inc.